z-logo
open-access-imgOpen Access
Synergistic use of synchrotron radiation techniques for biological samples in solution: a case study on protein‐ligand recognition by the peroxisomal import receptor Pex5p
Author(s) -
Stanley W. A.,
Sokolova A.,
Brown A.,
Clarke D. T.,
Wilmanns M.,
Svergun D. I.
Publication year - 2004
Publication title -
journal of synchrotron radiation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 99
ISSN - 1600-5775
DOI - 10.1107/s090904950402504x
Subject(s) - crystallography , scattering , circular dichroism , small angle x ray scattering , synchrotron radiation , synchrotron , chemistry , protein structure , structural biology , protein secondary structure , crystal structure , physics , optics , biochemistry
Circular dichroism spectropolarimetry and X‐ray scattering data, obtained using synchrotron radiation, can yield information about the secondary and tertiary structure of proteins in solution. These techniques have been used to analyse the architecture and shape of a complex of two proteins in solution. The crystal structures of two separate proteins, the C‐terminal domain of Pex5p and SCP2, are available but their complex has not previously been structurally characterized. Circular dichroism spectropolarimetry indicated that complex formation requires little secondary structure rearrangement. X‐ray scattering data fit an elongated irregular `shoe'‐shaped particle of the complex of the two proteins, with dimensions of the order of 30 Å× 40 Å× 90 Å. Comparison with the known crystal structures suggests that this `shoe' shape requires a conformational change of the C‐terminus of SCP2 to appropriately locate its peroxisomal targeting signal type‐1 recognition motif into the binding pocket of the Pex5p receptor. Implications of the combined use of synchrotron‐based circular dichroism spectropolarimetry and X‐ray scattering in structural biology and proteomics are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here